$NYXH News

Last published 6d ago

6d agoNYXHNyxoah Reports Third Quarter 2026 Financial and Operating ResultsGlobeNewswireREGULATED INFORMATION Nyxoah Reports Third Quarter 2026 Financial and Operating Results Global net revenue was €9.2 million driven by 29% sequential U.S. net revenue growthPMA supplement submitted to the FDA to expand
6d agoNYXHNyxoah Third Quarter 2026 Earnings Conference Call - NYXOAH SAEarnings Call TranscriptsGood day and thank you for standing by. Welcome to the NCSOA third quarter 2026 earnings conference call. At this time all participants are in a listen only mode. After the speaker's presentation there will be a question
2w agoNYXHNyxoah to Release Third Quarter 2026 Financial Results on November 5, 2026GlobeNewswireNyxoah to Release Third Quarter 2026 Financial Results on November 5, 2026 Mont-Saint-Guibert, Belgium – October 26, 2026, 10:05 pm CET / 5:05 pm ET – Nyxoah SA (Euronext Brussels/NASDAQ:NYXH) ("Nyxoah" or the
3w agoNYXHNyxoah Announces Preliminary Results for the Third Quarter of 2026 and Adjusts Revenue Guidance for 2026GlobeNewswireREGULATED INFORMATIONINSIDE INFORMATION Nyxoah Announces Preliminary Results for the Third Quarter of 2026 and Adjusts Revenue Guidance for 2026 U.S. net revenue grows 29% sequentially, driving third quarter global
3w agoNYXHFull 12-Month Data from the ACCCESS U.S. Pivotal Study in Complete Concentric Collapse Patients Presented at ISSS 2026GlobeNewswireFull 12-Month Data from the ACCCESS U.S. Pivotal Study in Complete Concentric Collapse Patients Presented at ISSS 2026 Genio® bilateral stimulation delivered a 74.3% median reduction in AHI at 12 months, with no
1mo agoCVRX NYXH VAPOCVRx Appoints John Landry as Chief Financial OfficerGlobeNewswireMINNEAPOLIS, Sept. 21, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ:CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation
1mo agoNYXHNyxoah Announces Chief Financial Officer TransitionGlobeNewswireREGULATED INFORMATIONINSIDE INFORMATION Nyxoah Announces Chief Financial Officer Transition Loïc Moreau, Nyxoah’s President International and former CFO, to serve as interim CFO Company reaffirms full year 2026
2mo agoNYXHNyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® SystemGlobeNewswireNyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System BREATHE is scheduled to implant up to 229 patients at up to 25 U.S. centers, followed for up to five years, to
2mo agoNYXHNyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints in Complete Concentric Collapse PatientsGlobeNewswireREGULATED INFORMATION INSIDE INFORMATION Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints in Complete Concentric Collapse Patients Reports an Apnea-Hypopnea Index (AHI) responder
2mo agoNYXHInformation on the total number of voting rights and sharesGlobeNewswireREGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), August 25, 2026, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on
3mo agoNYXHNyxoah Second Quarter 2026 Earnings Conference Call - NYXOAH SAEarnings Call TranscriptsGood day and thank you for standing by. Welcome to Nexos' second quarter 2026 earnings conference call. At this time, all participants are in a listen-only mode. After this speaker's presentation, there will be a questio
3mo agoNYXHNyxoah Reports Second Quarter and First Half 2026 Financial and Operating ResultsGlobeNewswireREGULATED INFORMATION Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating Results U.S. commercial execution driving continued launch momentum resulting in 22% sequential U.S. revenue growth in Q2
3mo agoNYXHNyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026GlobeNewswireNyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026 Mont-Saint-Guibert, Belgium – July 27, 2026, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the
4mo agoNYXHNyxoah Announces Preliminary Results for the Second Quarter of 2026GlobeNewswireNyxoah Announces Preliminary Results for the Second Quarter of 2026 Continued U.S. launch momentum drives second quarter global preliminary net revenue of €7.7 millionCMS proposes 2027 OPPS and ASC payment increase of
4mo agoNYXHInformation on the total number of voting rights and sharesGlobeNewswireREGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), June 30, 2026, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of May 2, 2007 on the
4mo agoNYXHPublication relating to transparency notificationsGlobeNewswireREGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), June 29, 2026, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Law of May 2, 2007 on
4mo agoNYXHNyxoah to Host Investor Day in New York on July 8, 2026GlobeNewswireNyxoah to Host Investor Day in New York on July 8, 2026 Leadership team and Board will discuss the U.S. commercial execution, growth strategy and key priorities Mont-Saint-Guibert, Belgium – June 23, 2026, 10:05 pm
4mo agoNYXHInvitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 9, 2026GlobeNewswireREGULATED INFORMATIONJune 19, 2026, 10:30pm CET / 4:30pm ET NYXOAH SA(Euronext Brussels/Nasdaq: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter the "Company") Invitation to attend the
4mo agoNYXHPublication relating to transparency notificationsGlobeNewswireREGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), June 17, 2026, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Law of May 2, 2007 on the
4mo agoNYXHNyxoah Receives $15 Million from the European Investment BankGlobeNewswireNyxoah Receives $15 Million from the European Investment Bank Non-dilutive debt funding complements the Company's June equity raise, bringing total capital raised to $110 million Mont-Saint-Guibert, Belgium – June 17,
5mo agoNYXHInformation on the total number of voting rights and sharesGlobeNewswireREGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), June 10, 2026, 11:00 pm CET / 5:00 pm ET – In accordance with article 15 of the Law of May 2, 2007 on the
5mo agoNYXH$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial LaunchGlobeNewswire$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial Launch Mont-Saint-Guibert, Belgium – June 10, 2026, 10:30 pm CET / 04:30 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or
5mo agoNYXHNyxoah Announces Closing of Underwritten Public OfferingGlobeNewswireREGULATED INFORMATION Nyxoah Announces Closing of Underwritten Public Offering Mont-Saint-Guibert, Belgium – June 10, 2026, 10:05 pm CET / 4:05 pm ET – Nyxoah SA (Euronext Brussels/ Nasdaq: NYXH) ("Nyxoah" or the
5mo agoNYXHNyxoah Announces Pricing of $95 Million Underwritten Public OfferingGlobeNewswireINSIDE INFORMATION REGULATED INFORMATION Nyxoah Announces Pricing of $95 Million Underwritten Public Offering Mont-Saint-Guibert, Belgium – June 5, 2026, 5:25 pm CET / 11:25 am ET – Nyxoah SA (Euronext
5mo agoNYXHNyxoah Announces Proposed Offering of Ordinary SharesGlobeNewswireINSIDE INFORMATION REGULATED INFORMATION Nyxoah Announces Proposed Offering of Ordinary Shares Mont-Saint-Guibert, Belgium – June 4, 2026, 10:02 pm CET / 4:02 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)
5mo agoNYXHNyxoah Enters New Chapter of Long Term Value CreationGlobeNewswireINSIDE INFORMATION REGULATED INFORMATION Nyxoah Enters New Chapter of Long Term Value Creation Commencement of process to transition to a U.S.-based CEOTransition to support further acceleration of commercial Genio
5mo agoNYXHInformation on the total number of voting rights and sharesGlobeNewswireREGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), May 20, 2026, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the
6mo agoNYXH2026 GLOBAL HEALTHCARE CONFERENCENYXOAH SAEarnings Call TranscriptsGood afternoon, everyone. First of all, thank you. And thank you, Bank of America, for having us and to be able to explain a little bit and talk a little more about the Nixoa story. When we talk about Nixova, we are talk
6mo agoNYXHNyxoah First Quarter 2026 Earnings Conference CallNYXOAH SAEarnings Call TranscriptsGood day, and thank you for standing by. Welcome to the NXOA First Quarter 2026 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there'll be a question
6mo agoNYXHNyxoah Reports First Quarter 2026 Financial and Operating ResultsGlobeNewswireREGULATED INFORMATION Nyxoah Reports First Quarter 2026 Financial and Operating Results Strong Genio launch in the U.S. drove 25% sequential quarterly U.S. revenue growth Continued clarity around HGNS and Genio
6mo agoNYXHInvitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 10, 2026GlobeNewswireREGULATED INFORMATIONMay 8, 2026, 10:05pm CET / 4:05pm ET NYXOAH SA(Euronext Brussels/Nasdaq: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter the "Company") Invitation to attend the annual and
6mo agoNYXHNyxoah to Participate in the Bank of America 2026 Healthcare ConferenceGlobeNewswireNyxoah to Participate in the Bank of America 2026 Healthcare Conference Mont-Saint-Guibert, Belgium – April 30, 2026, 10:05 pm CET / 4:05 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"), a
6mo agoNYXHNyxoah to Release First Quarter 2026 Financial Results on May 12, 2026GlobeNewswireNyxoah to Release First Quarter 2026 Financial Results on May 12, 2026 Mont-Saint-Guibert, Belgium – April 28, 2026, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"), that
7mo agoNYXHNyxoah Fourth Quarter 2025 Earnings Conference CallNYXOAH SAEarnings Call TranscriptsGood day and thank you for standing by. Welcome to the Nixoa fourth quarter full year 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, we'll open
8mo agoNYXHPublication relating to transparency notificationGlobeNewswireREGULATED INFORMATION Publication relating to transparency notification Mont-Saint-Guibert (Belgium), March 13, 2026, 10:30 pm CET / 5:30 pm ET – In accordance with article 14 of the Law of May 2, 2007 on the
8mo agoNYXHNyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026GlobeNewswireNyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026 Mont-Saint-Guibert, Belgium – March 5 2026, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the
8mo agoNYXHPublication relating to transparency notificationsGlobeNewswireREGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), February 27, 2026, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the
8mo agoNYXHInformation on the total number of voting rights and sharesGlobeNewswireREGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), February 25, 2026, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on
8mo agoNYXHNyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle EastGlobeNewswireNyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East Mont-Saint-Guibert, Belgium
9mo agoNYXHNyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide GrowthGlobeNewswireNyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth Mont-Saint-Guibert, Belgium – January 21, 2026, 10:05 pm CET / 4:05 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq:
10mo agoNYXHNyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2025 and Provides Revenue Guidance for the First Quarter of 2026GlobeNewswireINSIDE INFORMATIONREGULATED INFORMATION Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2025 and Provides Revenue Guidance for the First Quarter of 2026 Strong Start in First Full Quarter of
10mo agoNYXHPublication relating to transparency notificationGlobeNewswireREGULATED INFORMATION Publication relating to transparency notification Mont-Saint-Guibert (Belgium), January 12, 2026, 7:00 am CET / 1:00 am ET – In accordance with article 14 of the Law of May 2, 2007 on the
10mo agoNYXHNyxoah to Present at the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswireNyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference Mont-Saint-Guibert, Belgium – December 29, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"), a
10mo agoNYXHNyxoah Announces Issuance of First Tranche of Convertible BondsGlobeNewswireNyxoah Announces Issuance of First Tranche of Convertible Bonds Mont-Saint-Guibert, Belgium – December 19, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"), a
11mo agoNYXHNyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the NetherlandsGlobeNewswireNyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the NetherlandsFirst Genio implants successfully performed at OLVG West and Zuyderland hospitals Mont-Saint-Guibert, Belgium – December 17, 2025,
11mo agoNYXHPublication relating to transparency notificationsGlobeNewswireREGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), December 2, 2025, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May
11mo agoNYXHNyxoah to Participate in the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswireNyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference Mont-Saint-Guibert, Belgium – 27 November, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the
11mo agoNYXHNyxoah's Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS RuleGlobeNewswireNyxoah's Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule Assignment to New Technology APC 1580 is positive news for Nyxoah's U.S. commercial rollout by strengthening
11mo agoNYXHInformation on the total number of voting rights and sharesGlobeNewswireREGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), November 20, 2025, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on
12mo agoNYXHNyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of GenioGlobeNewswireINSIDE INFORMATIONREGULATED INFORMATION Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio Financings are comprised of equity investments, including from Cochlear,